Dr Agarwals Eye Hospital: Fixation of Record Date w.r.t. the scheme of amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr.…
Dr Agarwals Eye Hospital (DRAGARWQ) filed a disclosure titled "Fixation of Record Date w.r.t. the scheme of amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care Limited, is submitted". The company is valued at about ₹2,454…
What happened
Dr Agarwals Eye Hospital (DRAGARWQ) filed a disclosure with the exchanges on 20 October 2026 at 07:46 PM titled "Fixation of Record Date w.r.t. the scheme of amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care Limited, is submitted".
Company snapshot
Dr Agarwals Eye Hospital is a small-cap company, with a market value of about ₹2,454 crore.
The stock last traded at ₹5,077, against a 52-week range of ₹4,600–₹6,059.7 (16.2% below the high).
Before this filing the shares had moved −3.6% over the month and +1.2% over three months. Average daily turnover over the last 20 sessions was about ₹1.31 crore.
Promoters held 72.67% at the end of Q1 FY27; 7.67% of promoter shares were pledged. Foreign institutions owned 2.24% and domestic institutions 2.05%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 117 | 17.3 | 36.72 |
| Q2 FY26 | 118 | 19.3 | 41.04 |
| Q3 FY26 | 116 | 17.3 | 35.76 |
| Q4 FY26 | 120 | 16.2 | 33.6 |
| Q1 FY27 | 143 | 23.4 | 48.38 |
What history shows
This is not the company's first m&a disclosure: BCEIE has 4 earlier filings of this kind on record since May 2026.
After those filings, the stock gained 0.7% on average the next trading day and was up 0.5% on average after five days (3 filings with price data).
Market-wide, 2,117 m&a filings with an impact score of 50 or more saw an average next-day move of +0.4%, with 49% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 5 Oct 2026 | Receipt of sanction from the Honble NCLT, Chennai bench towards the… | −0.5% | — |
| 1 Jun 2026 | M&A | +1.3% | +0.5% |
| 1 Jun 2026 | M&A | +1.3% | +0.5% |
What to watch
- Regulatory approvals, completion of the deal and its effect on revenue and margins.
In the news
Recent coverage elsewhere (links open the original publisher):
- Dr Agarwals Eye Hospital Expands Delhi NCR Network To 15 Centres
- Dr Agarwals Eye Hospital and Dr Agarwals Institute of Optometry marks World Sight Day
- Dr Agarwals Eye Hospital Launches New Eye Care Centre in Sunkadakatte, Bengaluru
- Dr Agarwals Opens 17th Bengaluru Centre, Bringing Specialised Eye Care Closer to Patients
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.